Cindy Hutnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cindy Hutnik has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
Hong Liu
Department of Ophthalmology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
7 shared publications- James Jacob Armstrong
Schulich School of Medicine & Dentistry, Western University, London, ON, Canada; Ivey Eye Institute, St. Joseph's Health Care, London, ON, Canada; Department of Ophthalmology, Western University, ON, Canada
6 shared publications - Monali S. Malvankar-Mehta
Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada
6 shared publications - Michael Huang
Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, ON, Canada
3 shared publications - Vinay Kansal
University of Saskatchewan, Department of Ophthalmology, Saskatoon, Canada
3 shared publications Alex Mao
Ivey Eye Institute, Western University, London, Ont
2 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Understanding the landscape and building partnerships to plan a pragmatic trial of accessible mental health support for Canadians with eye diseases: A Protocol (Preprint)
UNSTRUCTURED Introduction This qualitative study aims to explore the perspectives of glaucoma patients as well as their physicians and ophthalmic nurses on the acceptability and feasibility of a proposed virtual intervention where glaucoma patients are taught breathing exercises and meditation in order to improve their quality of life. Using the Theoretical Domains Framework (TDF) to guide data collection and analysis, semi-structured interviews will be conducted with 15 participants from each stakeholder group (total N = 45). Participants will be asked questions regarding perceived barriers and facilitators to the implementation of breathing exercises and meditation in a clinical setting, and their perceptions regarding breathing exercises and meditation as an intervention. Methods and Analysis Interviews will be conducted virtually using Microsoft Teams, provided by St. Joseph’s Health Care London. Each interview will be audio-recorded, transcribed, and anonymized. Thematic analysis of anonymized data will be used to identify key barriers and facilitators to the intervention mapped to various TDF domains. Ethics and Dissemination This study has been approved by the Western Health Sciences Research Ethics Board (ID #128884). Findings will be disseminated through peer-reviewed publications, presentations, and will also be shared with the leadership and clinical staff at St. Joseph’s Health Care London. What is already known on this topic Previous studies have shown that breathing exercises and meditation may play a role in improving quality of life in some glaucoma patients, but little research has been done investigating how and when breathing exercises and meditation can be implemented more effectively for glaucoma patients. What this study adds By investigating perceived barriers and facilitators to implementing breathing exercises and meditation, as well as attitudes towards the intervention, this study aims to help researchers and physicians understand the potential challenges associated with using breathing exercises and meditation to improve quality of life for glaucoma patients. How this study might affect research, practice, or policy The findings will directly inform the optimal design of the intervention, as well as potential implementation strategies of the intervention in clinical settings, ensuring it is patient-centered and practically viable in real-world scenarios.
- 22 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnderstanding the landscape and building partnerships to plan a pragmatic trial of accessible mental health support for Canadians with eye diseases: A Protocol (Preprint)
UNSTRUCTURED Introduction This qualitative study aims to explore the perspectives of glaucoma patients as well as their physicians and ophthalmic nurses on the acceptability and feasibility of a proposed virtual intervention where glaucoma patients are taught breathing exercises and meditation in order to improve their quality of life. Using the Theoretical Domains Framework (TDF) to guide data collection and analysis, semi-structured interviews will be conducted with 15 participants from each stakeholder group (total N = 45). Participants will be asked questions regarding perceived barriers and facilitators to the implementation of breathing exercises and meditation in a clinical setting, and their perceptions regarding breathing exercises and meditation as an intervention. Methods and Analysis Interviews will be conducted virtually using Microsoft Teams, provided by St. Joseph’s Health Care London. Each interview will be audio-recorded, transcribed, and anonymized. Thematic analysis of anonymized data will be used to identify key barriers and facilitators to the intervention mapped to various TDF domains. Ethics and Dissemination This study has been approved by the Western Health Sciences Research Ethics Board (ID #128884). Findings will be disseminated through peer-reviewed publications, presentations, and will also be shared with the leadership and clinical staff at St. Joseph’s Health Care London. What is already known on this topic Previous studies have shown that breathing exercises and meditation may play a role in improving quality of life in some glaucoma patients, but little research has been done investigating how and when breathing exercises and meditation can be implemented more effectively for glaucoma patients. What this study adds By investigating perceived barriers and facilitators to implementing breathing exercises and meditation, as well as attitudes towards the intervention, this study aims to help researchers and physicians understand the potential challenges associated with using breathing exercises and meditation to improve quality of life for glaucoma patients. How this study might affect research, practice, or policy The findings will directly inform the optimal design of the intervention, as well as potential implementation strategies of the intervention in clinical settings, ensuring it is patient-centered and practically viable in real-world scenarios.
- Open Access
- 13 October 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (6) , 1359-1378
Patient-reported outcome measures in cataract surgery: systematic review and meta-analysis of visual function and quality of life
- 13 October 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (6) , 1359-1378
Open AccessPatient-reported outcome measures in cataract surgery: systematic review and meta-analysis of visual function and quality of life
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-17
The Effects of Breathing Exercises and Meditation on Quality of Life Among Eye Disease Patients: A Systematic Review
Background: Those diagnosed with eye disease are at a higher risk for experiencing a decreased quality of life (QOL). Meditation and breathing exercises have been linked with improvements in this area, but research in populations of eye disease patients is relatively scarce. We aim to bridge this knowledge gap by synthesizing the available evidence on the effects of meditation and breathing exercises on QOL in those with eye diseases. Methods: A scoping search was performed in PubMed, Embase, CENTRAL, Web of Science, and CINAHL databases up to September 16th, 2025, to find relevant studies for review. Inclusion criteria were experimental studies investigating meditation or breathing exercises on any QOL outcome in populations with any eye disease. Study quality was assessed with the Cochrane Risk-of-bias tool and the Modified Downs and Black Checklist. Results: Of the seven studies, six RCTs and one single-arm trial were included. Five studies examined QOL as an outcome, while four measured anxiety symptoms, two measured depression symptoms, and two measured sleep quality. Overall, beneficial effects of meditation and breathing exercises on these outcomes were found, although there were concerns with study quality and follow-up length. Conclusion: While preliminary findings suggest that meditation and breathing exercises may improve QOL for individuals with eye diseases, additional studies are required to establish the definitive impact of these interventions on the well-being of patients with eye conditions. Studies with longer follow-up times and higher methodological quality would be useful in continuing to explore the effects of these interventions on QOL outcomes.
- 1 August 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-17
Open AccessThe Effects of Breathing Exercises and Meditation on Quality of Life Among Eye Disease Patients: A Systematic Review
Background: Those diagnosed with eye disease are at a higher risk for experiencing a decreased quality of life (QOL). Meditation and breathing exercises have been linked with improvements in this area, but research in populations of eye disease patients is relatively scarce. We aim to bridge this knowledge gap by synthesizing the available evidence on the effects of meditation and breathing exercises on QOL in those with eye diseases. Methods: A scoping search was performed in PubMed, Embase, CENTRAL, Web of Science, and CINAHL databases up to September 16th, 2025, to find relevant studies for review. Inclusion criteria were experimental studies investigating meditation or breathing exercises on any QOL outcome in populations with any eye disease. Study quality was assessed with the Cochrane Risk-of-bias tool and the Modified Downs and Black Checklist. Results: Of the seven studies, six RCTs and one single-arm trial were included. Five studies examined QOL as an outcome, while four measured anxiety symptoms, two measured depression symptoms, and two measured sleep quality. Overall, beneficial effects of meditation and breathing exercises on these outcomes were found, although there were concerns with study quality and follow-up length. Conclusion: While preliminary findings suggest that meditation and breathing exercises may improve QOL for individuals with eye diseases, additional studies are required to establish the definitive impact of these interventions on the well-being of patients with eye conditions. Studies with longer follow-up times and higher methodological quality would be useful in continuing to explore the effects of these interventions on QOL outcomes.
- 20 May 2026
- Published by Springer Nature in Eye
- Vol. 40 (11) , 1593-1595
AI agents: a game changer in ophthalmology?
- 20 May 2026
- Published by Springer Nature in Eye
- Vol. 40 (11) , 1593-1595
AI agents: a game changer in ophthalmology?
- Open Access
- 1 April 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Preservative-free 0.01% bimatoprost versus other formulations for glaucoma and OHT: Systematic review and meta-analysis of efficacy and safety
Purpose: To demonstrate non-inferiority on efficacy and safety of preservative-free bimatoprost 0.01% versus preserved and higher-concentration bimatoprost formulations for the treatment of glaucoma or ocular hypertension (OHT), using a network meta-analysis (NMA). Methods: A systematic review and Bayesian NMA were conducted according to a pre-registered protocol (PROSPERO: CRD420250650769) and PRISMA-NMA guidelines. Randomised controlled trials comparing monotherapies of bimatoprost (preserved or preservative-free) in adults with glaucoma or OHT were included. The primary endpoint was mean intraocular pressure (IOP) at Week 12. Conjunctival hyperaemia, were descriptively analysed. Risk of bias was assessed using the Cochrane RoB 2 tool. Results: Four studies were included. The Bayesian NMA demonstrated that preservative-free bimatoprost 0.01% was non-inferior to all other bimatoprost formulations in lowering IOP, with all 95% credible intervals falling within the 1.5 mmHg non-inferiority margin. Sensitivity analyses using a frequentist model confirmed these findings. Safety analysis indicated that preservative-free bimatoprost formulations were associated with lower rates of hyperaemia compared to preserved versions. At Week 12, more patients had no hyperaemia with preservative-free bimatoprost 0.01% (57.3% vs. 43.6%) and fewer showed worsening scores (18.3% vs. 30.4%). Hyperaemia reported as an adverse event was also less frequent with bimatoprost 0.01% than 0.03% (28.6% vs. 37.4%). Conclusions: Preservative-free bimatoprost 0.01% provided IOP-lowering efficacy similar to preserved or higher-dose bimatoprost, with less occurrence of conjunctival hyperaemia. Further long-term studies are needed to confirm these benefits.
- 1 April 2026
- Published by SAGE Publications in European Journal of Ophthalmology
Open AccessPreservative-free 0.01% bimatoprost versus other formulations for glaucoma and OHT: Systematic review and meta-analysis of efficacy and safety
Purpose: To demonstrate non-inferiority on efficacy and safety of preservative-free bimatoprost 0.01% versus preserved and higher-concentration bimatoprost formulations for the treatment of glaucoma or ocular hypertension (OHT), using a network meta-analysis (NMA). Methods: A systematic review and Bayesian NMA were conducted according to a pre-registered protocol (PROSPERO: CRD420250650769) and PRISMA-NMA guidelines. Randomised controlled trials comparing monotherapies of bimatoprost (preserved or preservative-free) in adults with glaucoma or OHT were included. The primary endpoint was mean intraocular pressure (IOP) at Week 12. Conjunctival hyperaemia, were descriptively analysed. Risk of bias was assessed using the Cochrane RoB 2 tool. Results: Four studies were included. The Bayesian NMA demonstrated that preservative-free bimatoprost 0.01% was non-inferior to all other bimatoprost formulations in lowering IOP, with all 95% credible intervals falling within the 1.5 mmHg non-inferiority margin. Sensitivity analyses using a frequentist model confirmed these findings. Safety analysis indicated that preservative-free bimatoprost formulations were associated with lower rates of hyperaemia compared to preserved versions. At Week 12, more patients had no hyperaemia with preservative-free bimatoprost 0.01% (57.3% vs. 43.6%) and fewer showed worsening scores (18.3% vs. 30.4%). Hyperaemia reported as an adverse event was also less frequent with bimatoprost 0.01% than 0.03% (28.6% vs. 37.4%). Conclusions: Preservative-free bimatoprost 0.01% provided IOP-lowering efficacy similar to preserved or higher-dose bimatoprost, with less occurrence of conjunctival hyperaemia. Further long-term studies are needed to confirm these benefits.
- 21 February 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (3) , 787-789
Sedation for cataract surgery: a survey of Ontario and Quebec ophthalmologists
- 21 February 2026
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (3) , 787-789
Sedation for cataract surgery: a survey of Ontario and Quebec ophthalmologists
- Open Access
- 22 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
Selective Laser Trabeculoplasty Compared to Medication for Open‐Angle Glaucoma Patients: A Systematic Review and Meta‐Analysis
Background: An alternative glaucoma treatment is selective laser trabeculoplasty (SLT) that can effectively reduce intraocular pressure (IOP) and decrease the burden of glaucoma management. With newly published randomized controlled trials (RCTs) comparing SLT and medication, an updated systematic review and meta‐analysis was needed. Methods: A literature search of RCTs comparing SLT and medication in open‐angle glaucoma patients was conducted until January 12, 2024 in CINAHL, Cochrane Library, EMBASE, MEDLINE, Web of Science, ClinicalTrials.gov, and Dissertations and Theses databases. Cochrane Risk of Bias 2 (ROB2) was used to assess the quality of the included RCTs. Results: The included 16 RCTs comprised 2412 patients. At 26 weeks, the combination treatment of SLT and medication had a significant IOP reduction (SMD = 0.78, 95% CI = [0.56, 1.01], p < 0.01, I 2 = 0.00%). At 52 weeks or longer, both the SLT group (SMD = 1.91, 95% CI = [1.55, I 2 = 73.99%) and the medication group (SMD = 1.70, 95% CI = [1.01, 2.38], p < 0.01, I 2 = 92.87%) had significant IOP reduction. At 6 months, the combination treatment significantly reduced the mean number of medications used by 0.78 (SMD = 0.78, 95% CI = [0.56, 1.01], p < 0.01, I 2 = 0.00%) where the medication treatment had no significant decrease (SMD = −0.01, 95% CI = [−0.23, 0.21], p = 0.93, I 2 = 0.00%). Quality of life between participants in the SLT and medication groups was found to be similar. Conclusion: Long‐term IOP reduction was greater in the SLT treatment compared to medication. SLT treatment significantly reduced the number of medications used by participants whereas medication group had no significant change.
- 22 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1)
Open AccessSelective Laser Trabeculoplasty Compared to Medication for Open‐Angle Glaucoma Patients: A Systematic Review and Meta‐Analysis
Background: An alternative glaucoma treatment is selective laser trabeculoplasty (SLT) that can effectively reduce intraocular pressure (IOP) and decrease the burden of glaucoma management. With newly published randomized controlled trials (RCTs) comparing SLT and medication, an updated systematic review and meta‐analysis was needed. Methods: A literature search of RCTs comparing SLT and medication in open‐angle glaucoma patients was conducted until January 12, 2024 in CINAHL, Cochrane Library, EMBASE, MEDLINE, Web of Science, ClinicalTrials.gov, and Dissertations and Theses databases. Cochrane Risk of Bias 2 (ROB2) was used to assess the quality of the included RCTs. Results: The included 16 RCTs comprised 2412 patients. At 26 weeks, the combination treatment of SLT and medication had a significant IOP reduction (SMD = 0.78, 95% CI = [0.56, 1.01], p < 0.01, I 2 = 0.00%). At 52 weeks or longer, both the SLT group (SMD = 1.91, 95% CI = [1.55, I 2 = 73.99%) and the medication group (SMD = 1.70, 95% CI = [1.01, 2.38], p < 0.01, I 2 = 92.87%) had significant IOP reduction. At 6 months, the combination treatment significantly reduced the mean number of medications used by 0.78 (SMD = 0.78, 95% CI = [0.56, 1.01], p < 0.01, I 2 = 0.00%) where the medication treatment had no significant decrease (SMD = −0.01, 95% CI = [−0.23, 0.21], p = 0.93, I 2 = 0.00%). Quality of life between participants in the SLT and medication groups was found to be similar. Conclusion: Long‐term IOP reduction was greater in the SLT treatment compared to medication. SLT treatment significantly reduced the number of medications used by participants whereas medication group had no significant change.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 1041
Reply: Intravenous vs nonintravenous sedation for cataract surgery: systematic review and meta-analysis
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 1041
Reply: Intravenous vs nonintravenous sedation for cataract surgery: systematic review and meta-analysis
- Open Access
- 3 October 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (1) , 147-155
Anterior vitrectomy incidence in cataract surgery among experienced surgeons and residents: A systematic review and meta-analysis
Purpose: Cataract surgery is a fundamental procedure in ophthalmology, yet intraoperative complications such as anterior vitrectomy can compromise surgical outcomes. This systematic review and meta-analysis (CRD42025637001) aim to compare the incidence of anterior vitrectomy in cataract surgeries performed by ophthalmology residents versus experienced surgeons and assess factors contributing to surgical complications. Methods: A systematic search was conducted across EMBASE, MEDLINE, CINAHL Plus, Web of Science, ClinicalTrials.gov, PQDT Global, ARVO and AAO for studies published after 2000 that reported on anterior vitrectomy incidence in cataract surgery. Eligible studies included randomized controlled trials and observational studies. Meta-analysis was performed using STATA v. 18.0. Results: Out of 1,190 screened studies, five studies (four retrospective cohort, one prospective cohort) involving phacoemulsification, extracapsular cataract extraction (ECCE), and femtosecond laser-assisted cataract surgery (FLACS) were included, encompassing a total of 4,918 cataract surgeries, and 208 anterior vitrectomy (AV) cases. The random-effects meta-analysis demonstrated a significant AV incidence for residents (ES = 0.04, 95% CI: [0.01, 0.06]), while the incidence for experienced surgeons was not statistically significant (ES = 0.03, 95% CI: [−0.03, 0.09]). High heterogeneity was observed among the included studies (I² = 92.1% for residents and I² = 96.7% for surgeons). Conclusion: Residents may have a higher incidence of AV, highlighting the potential benefits of structured surgical training, early exposure, and mentorship in reducing intraoperative complications. Future research should explore simulation-based training and technology-assisted surgery to improve resident proficiency and patient outcomes.
- 3 October 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (1) , 147-155
Open AccessAnterior vitrectomy incidence in cataract surgery among experienced surgeons and residents: A systematic review and meta-analysis
Purpose: Cataract surgery is a fundamental procedure in ophthalmology, yet intraoperative complications such as anterior vitrectomy can compromise surgical outcomes. This systematic review and meta-analysis (CRD42025637001) aim to compare the incidence of anterior vitrectomy in cataract surgeries performed by ophthalmology residents versus experienced surgeons and assess factors contributing to surgical complications. Methods: A systematic search was conducted across EMBASE, MEDLINE, CINAHL Plus, Web of Science, ClinicalTrials.gov, PQDT Global, ARVO and AAO for studies published after 2000 that reported on anterior vitrectomy incidence in cataract surgery. Eligible studies included randomized controlled trials and observational studies. Meta-analysis was performed using STATA v. 18.0. Results: Out of 1,190 screened studies, five studies (four retrospective cohort, one prospective cohort) involving phacoemulsification, extracapsular cataract extraction (ECCE), and femtosecond laser-assisted cataract surgery (FLACS) were included, encompassing a total of 4,918 cataract surgeries, and 208 anterior vitrectomy (AV) cases. The random-effects meta-analysis demonstrated a significant AV incidence for residents (ES = 0.04, 95% CI: [0.01, 0.06]), while the incidence for experienced surgeons was not statistically significant (ES = 0.03, 95% CI: [−0.03, 0.09]). High heterogeneity was observed among the included studies (I² = 92.1% for residents and I² = 96.7% for surgeons). Conclusion: Residents may have a higher incidence of AV, highlighting the potential benefits of structured surgical training, early exposure, and mentorship in reducing intraoperative complications. Future research should explore simulation-based training and technology-assisted surgery to improve resident proficiency and patient outcomes.